Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Brain Behav Immun. 2023 Jun 12;112:220–234. doi: 10.1016/j.bbi.2023.06.011

Fig. 4.

Fig. 4.

CFA does not affect sciatic nerve blood-nerve barrier permeability or inflammation. Representative image of sodium fluorescein (A) and Evans Blue Albumin (B) permeability in the sciatic nerves of female mice on day 3 following CFA or PBS controls (n=5, Scale bar 50 μm). (C) Quantification of leukocyte markers in the sciatic nerve on day 3 following CFA or PBS injection. (D) Quantification of cytokines/chemokines in the sciatic nerve on day 3 following CFA or PBS injection.